1. Home
  2. MRNS vs GRYP Comparison

MRNS vs GRYP Comparison

Compare MRNS & GRYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNS
  • GRYP
  • Stock Information
  • Founded
  • MRNS 2003
  • GRYP 2010
  • Country
  • MRNS United States
  • GRYP United States
  • Employees
  • MRNS N/A
  • GRYP N/A
  • Industry
  • MRNS Biotechnology: Pharmaceutical Preparations
  • GRYP
  • Sector
  • MRNS Health Care
  • GRYP
  • Exchange
  • MRNS Nasdaq
  • GRYP Nasdaq
  • Market Cap
  • MRNS 19.0M
  • GRYP 18.0M
  • IPO Year
  • MRNS 2014
  • GRYP N/A
  • Fundamental
  • Price
  • MRNS $0.30
  • GRYP $0.65
  • Analyst Decision
  • MRNS Buy
  • GRYP Hold
  • Analyst Count
  • MRNS 12
  • GRYP 1
  • Target Price
  • MRNS $4.28
  • GRYP N/A
  • AVG Volume (30 Days)
  • MRNS 6.6M
  • GRYP 1.2M
  • Earning Date
  • MRNS 11-12-2024
  • GRYP 11-13-2024
  • Dividend Yield
  • MRNS N/A
  • GRYP N/A
  • EPS Growth
  • MRNS N/A
  • GRYP N/A
  • EPS
  • MRNS N/A
  • GRYP N/A
  • Revenue
  • MRNS $31,466,000.00
  • GRYP $22,783,000.00
  • Revenue This Year
  • MRNS $20.74
  • GRYP N/A
  • Revenue Next Year
  • MRNS $32.38
  • GRYP N/A
  • P/E Ratio
  • MRNS N/A
  • GRYP N/A
  • Revenue Growth
  • MRNS 1.63
  • GRYP 14.06
  • 52 Week Low
  • MRNS $0.26
  • GRYP $0.38
  • 52 Week High
  • MRNS $11.26
  • GRYP $10.30
  • Technical
  • Relative Strength Index (RSI)
  • MRNS 25.07
  • GRYP 49.42
  • Support Level
  • MRNS $0.29
  • GRYP $0.56
  • Resistance Level
  • MRNS $0.37
  • GRYP $1.10
  • Average True Range (ATR)
  • MRNS 0.04
  • GRYP 0.13
  • MACD
  • MRNS 0.02
  • GRYP 0.01
  • Stochastic Oscillator
  • MRNS 17.95
  • GRYP 23.67

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

About GRYP Gryphon Digital Mining Inc Common Stock

Gryphon Digital Mining Inc is a Bitcoin mining company. Gryphon's mission is to create the world's leading net carbon-neutral Bitcoin miner. The company will operate a digital asset, mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips to solve complex cryptographic algorithms in support of the Bitcoin blockchain in exchange for cryptocurrency rewards (primarily Bitcoin).

Share on Social Networks: